5ZV3
Crystal structure of human anti-tau antibody CBTAU-28.1 in complex with its tau peptide
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | SSRL BEAMLINE BL12-2 |
| Synchrotron site | SSRL |
| Beamline | BL12-2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2014-12-02 |
| Detector | DECTRIS PILATUS3 S 6M |
| Wavelength(s) | 0.9795 |
| Spacegroup name | P 1 21 1 |
| Unit cell lengths | 77.241, 49.423, 61.375 |
| Unit cell angles | 90.00, 105.55, 90.00 |
Refinement procedure
| Resolution | 41.223 - 2.093 |
| R-factor | 0.1906 |
| Rwork | 0.187 |
| R-free | 0.25080 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 3QOT |
| RMSD bond length | 0.007 |
| RMSD bond angle | 0.952 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX ((1.10.1_2155: ???)) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 50.000 | 2.140 |
| High resolution limit [Å] | 2.090 | 2.100 |
| Rmerge | 0.120 | 0.520 |
| Rmeas | 0.150 | |
| Rpim | 0.080 | 0.650 |
| Number of reflections | 25910 | 3146 |
| <I/σ(I)> | 12.7 | 1.1 |
| Completeness [%] | 97.5 | 78.4 |
| Redundancy | 3.4 | 2.4 |
| CC(1/2) | 0.985 | 0.650 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, SITTING DROP | 8.5 | 293 | 0.085M Tris-HCl, pH 8.5, 0.17M sodium acetate, 25.5% PEG 4000 |






